171 related articles for article (PubMed ID: 18506592)
1. Pharmacophore mapping of flavone derivatives for aromatase inhibition.
Nagar S; Islam MA; Das S; Mukherjee A; Saha A
Mol Divers; 2008 Feb; 12(1):65-76. PubMed ID: 18506592
[TBL] [Abstract][Full Text] [Related]
2. Modeling of diarylalkyl-imidazole and diarylalkyl-triazole derivatives as potent aromatase inhibitors for treatment of hormone-dependent cancer.
Nagar S; Saha A
J Comput Chem; 2010 Sep; 31(12):2342-53. PubMed ID: 20340106
[TBL] [Abstract][Full Text] [Related]
3. 3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.
Xie H; Qiu K; Xie X
Int J Mol Sci; 2014 Nov; 15(11):20927-47. PubMed ID: 25405729
[TBL] [Abstract][Full Text] [Related]
4. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
Nagar S; Saha A
Eur J Med Chem; 2010 Sep; 45(9):4307-15. PubMed ID: 20638757
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
[TBL] [Abstract][Full Text] [Related]
6. Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.
Adhikari N; Amin SA; Saha A; Jha T
Eur J Med Chem; 2017 Sep; 137():365-438. PubMed ID: 28622580
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.
Leonetti F; Favia A; Rao A; Aliano R; Paluszcak A; Hartmann RW; Carotti A
J Med Chem; 2004 Dec; 47(27):6792-803. PubMed ID: 15615528
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore based 3D-QSAR study of biphenyl derivatives as nonsteroidal aromatase inhibitors in JEG-3 cell lines.
Bheemanapalli LN; Balakumar C; Kaki VR; Kaur R; Akkinepally RR
Med Chem; 2013 Nov; 9(7):974-84. PubMed ID: 22974288
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors.
Banjare L; Singh Y; Verma SK; Singh AK; Kumar P; Kumar S; Jain AK; Thareja S
J Biomol Struct Dyn; 2023 Mar; 41(4):1322-1341. PubMed ID: 34963408
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
[TBL] [Abstract][Full Text] [Related]
13. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme.
Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084
[TBL] [Abstract][Full Text] [Related]
14. Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors.
Adhikari N; Baidya SK; Jha T
Eur J Med Chem; 2020 Dec; 208():112845. PubMed ID: 33017749
[TBL] [Abstract][Full Text] [Related]
15. CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents.
Srivastava V; Kumar A; Mishra BN; Siddiqi MI
Bioinformation; 2008 Jun; 2(9):384-91. PubMed ID: 18795111
[TBL] [Abstract][Full Text] [Related]
16. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
Wang Y; Wu M; Ai C; Wang Y
Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
[TBL] [Abstract][Full Text] [Related]
17. Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.
Singh Y; Jaswal S; Singh S; Verma SK; Thareja S
J Biomol Struct Dyn; 2023 Dec; 41(20):10604-10626. PubMed ID: 36510679
[TBL] [Abstract][Full Text] [Related]
18. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
19. Role of Natural and Synthetic Flavonoids as Potential Aromatase Inhibitors in Breast Cancer: Structure-Activity Relationship Perspective.
Shah U; Patel A; Patel S; Patel M; Patel A; Patel S; Patel S; Maheshwari R; Mtewa AG; Gandhi K
Anticancer Agents Med Chem; 2022; 22(11):2063-2079. PubMed ID: 34702156
[TBL] [Abstract][Full Text] [Related]
20. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
Gunda SK; Narasimha SK; Shaik M
Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
